| Literature DB >> 19259264 |
Baris Tursun1, Luisa Cochella, Inés Carrera, Oliver Hobert.
Abstract
Engineering fluorescent proteins into large genomic clones, contained within BACs or fosmid vectors, is a tool to visualize and study spatiotemporal gene expression patterns in transgenic animals. Because these reporters cover large genomic regions, they most likely capture all cis-regulatory information and can therefore be expected to recapitulate all aspects of endogenous gene expression. Inserting tags at the target gene locus contained within genomic clones by homologous recombination ("recombineering") represents the most straightforward method to generate these reporters. In this methodology paper, we describe a simple and robust pipeline for recombineering of fosmids, which we apply to generate reporter constructs in the nematode C. elegans, whose genome is almost entirely covered in an available fosmid library. We have generated a toolkit that allows for insertion of fluorescent proteins (GFP, YFP, CFP, VENUS, mCherry) and affinity tags at specific target sites within fosmid clones in a virtually seamless manner. Our new pipeline is less complex and, in our hands, works more robustly than previously described recombineering strategies to generate reporter fusions for C. elegans expression studies. Furthermore, our toolkit provides a novel recombineering cassette which inserts a SL2-spliced intercistronic region between the gene of interest and the fluorescent protein, thus creating a reporter controlled by all 5' and 3' cis-acting regulatory elements of the examined gene without the direct translational fusion between the two. With this configuration, the onset of expression and tissue specificity of secreted, sub-cellular compartmentalized or short-lived gene products can be easily detected. We describe other applications of fosmid recombineering as well. The simplicity, speed and robustness of the recombineering pipeline described here should prompt the routine use of this strategy for expression studies in C. elegans.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19259264 PMCID: PMC2649505 DOI: 10.1371/journal.pone.0004625
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Timeline comparison of available recombineering protocols.
Figure 2Recombineering pipeline.
A cassette containing the tag of interest and the FRT-galK-FRT (FgF) selection module, and flanked by sequence homologous to the desired insertion site can be recombined into the gene of choice in the context of a fosmid genomic clone. Recombination is carried out in SW105, an E. coli strain with heat inducible λ Red recombinase. Recombinant clones are selected on minimal medium with galactose. Excision of the FgF selection module is carried out by Flp recombinase, which is induced by addition of arabinose. Excision is typically complete, but to aid in the isolation of pure recombineered fosmids selection for loss of galK can be done in medium containing deoxy-galactose. Note that the FRT “scar” left after galK excision resides in an intron and therefore has no impact on protein coding sequences. Also note that the cassette can be inserted anywhere.
Figure 3A bicistronic recombineering cassette.
This series of cassettes can be inserted between the stop codon and the 3′ UTR of the gene of interest. The recombination procedure is identical to that described for other cassettes but the end result is an operon-like configuration that after splicing and trans-splicing will give rise to two gene products: an unmodified protein of interest and a nuclear-localized fluorescent protein that reports the onset of expression and cellular focus of action of the protein of interest. Note that the endogenous protein loses its 3′ UTR but this remains on the reporter cistron and thus potential 3′ UTR-mediated gene regulation should be preserved. These cassettes are of particular use for subcellularly-compartmentalized or secreted proteins, or proteins with very short half-lives.
Fosmid recombineering cassettes.
| Cassettes ( | Plasmid name | Properties | 5′ sequence (X50 = gene specific sequence) | 3′sequence (X50 = gene specific sequence) |
|
| pBALU1 |
| ||
| N-terminal fusion | 5′ X50- |
| ||
| C-terminal fusion | 5′ X50- |
| ||
|
| pBALU2 | as above but with | ||
| N-terminal fusion | 5′ X50- |
| ||
| C-terminal fusion | 5′ X50- |
| ||
|
| pBALU3 | as above but with c | ||
| N-terminal fusion | 5′ X50- |
| ||
| C-terminal fusion | 5′ X50- |
| ||
|
| pBALU4 | as above but with | ||
| N-terminal fusion | 5′ X50- |
| ||
| C-terminal fusion | 5′ X50- |
| ||
|
| pBALU5 |
| 5′ X50- |
|
|
| pBALU6 | Venus in frame w/ | 5′ X50- |
|
|
| pBALU7 |
| 5′ X50- |
|
|
| pBALU8 pBALU8* |
| 5′ X50- |
|
|
| pBALU9 | bicistronic; | 5′ X50STOP- |
|
|
| pBALU10 pBALU10* |
| 5′ X50STOP- |
|
|
| pBALU11 |
| 5′ X50STOP- |
|
|
| pBALU12 |
| 5′ X50STOP- |
|
|
| pBALU13 | bicistronic; | 5′ X50STOP- |
|
|
| pBALU14 | bi- | 5′ X50STOP- |
|
|
| pBALU15 | bicistronic; | 5′ X50STOP- |
|
|
| pBALU16 pBALU16* |
| 5′ X50STOP- |
|
|
| pBALU17 pBALU17* |
| 5′ X50STOP- |
|
|
| pBALU18 pBALU18* |
| 5′ X50STOP- |
|
|
| pBALU19 | bicistronic; | 5′ X50STOP- |
|
|
| pBALU20 | bicistronic; | 5′ X50STOP- |
|
|
| pBALU21 | replaces endogenous 3′UTR; use C-term after STOP | 5′ X50
|
|
|
| pBALU-ext | extension at 5′ end: PCR fuse the cassette to the 3′ end of KAN gene: |
|
|
| extension at 3′ end: PCR fuse the cassette to the 5′ end of KAN gene: | 5′ X30- |
|
The vector backbone for the pBALU vectors is the pCR TOPO cloning vector (Invitrogen). For complete plasmid sequences, see Supplement Text S1.
Note that the intronless cassettes are specifically required to allow for double-recombineering with the intron-containing reporter genes. If there were overlap between the sequentially introduced reporters, undesired homologous recombination could occur. STOP represents the stop codon from the gene of interest. mChO (mChOpti) is an intron containing, and C. elegans codon usage optimized mCherry variant as described in McNally et al., 2006. For each vector series (e.g. pBALU15-18), at least one, if not all, color version was explicitly tested in recombineering reactions. The pBALU vectors that are also available with modified FRTs for double recombineering are labeled pBALUxx*.
Figure 4Double recombineering.
Two independent manipulations can be carried out on the same fosmid molecule. The two recombinations are done sequentially, each one in the same way as previously described. Note that the second cassette cannot include FRT sites as an FRT site remains after the first recombination and Flp can potentially recombine any two of the three inserted FRT sites. To circumvent this we have introduced an FRT* variant that is still recognized by Flp but does not cross react with the original FRT sequence.
Reagents.
|
|
|
|
|
|
|
| 10 g NaCl; 5 g Yeast Extract; 10 g Bacto-Tryptone; adjust volume to 1 L with H2O and autoclave. After cooling to ∼55°C, add 250 µl 50 mg/mL chloramphenicol. |
|
| 10 g NaCl; 5 g Yeast Extract; 10 g Bacto-Tryptone; 15 g Agar; adjust volume to 1 L with H2O and autoclave. After cooling to ∼55°C, add 250 µl 50 mg/mL chloramphenicol. |
|
| 6 g Na2HPO4; 3 g KH2PO4; 1 g NH4Cl; 0.5 g NaCl; adjust volume to 1 L with H2O and autoclave. |
|
| Autoclave 15 g agar in 780 mL H2O. After cooling down to ∼55°C add 200 mL 5× M63 medium (10 g (NH4)2SO4; 68 g KH2PO4; 2.5 mg FeSO4·7H2O; adjust to pH 7 with KOH; adjust volume to 1 L with H2O and autoclave); 1 mL 1 M MgSO4·7H2O (sterile filtered); 10 ml 20% galactose (autoclaved); 5 mL 0.2 mg/mL d-biotin (sterile filtered); 4.5 mL 10 mg/mL L-leucine (heat up to ∼50°C to dissolve, let cool down- sterile filtered); and 250 µl 50 mg/mL chloramphenicol (in EtOH). |
|
| Autoclave 15 g agar in 780 mL H2O. After cooling down to ∼55°C add 200 mL 5× M63 medium; 1 mL 1 M MgSO4·7H2O; 10 ml 20% 2-deoxy-galactose (in H2O; autoclaved); 10 ml 20% glycerol (autoclaved); 5 mL 0.2 mg/mL d-biotin; 4.5 mL 10 mg/mL L-leucine; and 250 µl 50 mg/mL chloramphenicol |
|
| Prepare MacConkey agar adding galactose according to manufacturer's instructions (BD Difco, #281810). After autoclaving and cooling to ∼55°C, add 250 µl 50 mg/mL chloramphenicol per liter. |
|
| 10% L-arabinose in H2O, sterile filtered. |
Troubleshooting.
| Problem | Possible solutions |
| No PCR product with long primers | Vary annealing temperature in a gradient PCR |
| Add PCR enhancer solutions such as betaine or DMSO | |
| Order two sets of shorter primers and add the 50 bp of homology in two sequential reactions | |
| No colonies on | Confirm quality of competent cells and plates by electroporating control fosmid pBALUxx (contains Chl resistance and the |
| Electroporate more PCR product (up to 300 ng) | |
| Extend the homology arms of the cassette with an additional pair of primers (to 80–100 bp) | |
| Titrate heat-shock/induction time (no more than 25–30 min) | |
| Sequence desired recombineering site in the fosmid to confirm the annotated sequence | |
| Incomplete | Make fresh arabinose solution and induce for longer time |
| Streak out arabinose-induced bacteria on DOG plates to obtain single colonies that do not contain the | |
| No transgenic lines | Decrease fosmid concentration on array as overexpression might be toxic |
Rescue of mutant phenotypes with recombineered fosmids.
| fosmid recombineered gene | genetic background | # of lines | complete rescue | partial rescue | no rescue |
|
|
| 9 | 7 | 1 | 1 |
|
|
| 3 | 2 | 0 | 1 |
See Figure 6 and 7 for constructs. che-1 rescue was assessed by injecting the recombineered fosmid into mutants ot94; ntIs1 (gcy5prom::gfp) that display a 100% penetrant total loss of gfp expression. Rescued animals restore gfp expression in ASER. lsy-2 rescue was assessed by injecting recombineered fosmids into ot90; ntIs1 (gcy5prom::gfp) that display 100% penetrant ectopic gfp expression in ASEL. Rescued animals show gfp expression only in ASER. For each line at least 20 L4 worms were scored.
100% of animals show rescue.
>50% of animals show rescue.
No rescue and no reporter expression.
Figure 5lsy-2 reporter generated by fosmid recombineering.
A. lsy-2 locus. Complete fosmid coverage of the lsy-2 locus is shown and the fosmid that was chosen for recombineering is highlighted in red. The pBALU 2 cassette was used to create a C-terminal fusion protein of LSY-2 and YFP. B. Embryonic expression. The recombineered fosmid was injected into lsy-2 mutant strain lsy-2(ot90) mutant containing the ASER specific marker gcy-5prom::gfp. The comma stage embryo displays broad expression of lsy-2::yfp. The reporter gcy-5prom::gfp is not detectable since its earliest expression is at the later 3fold stage. C. Larval expression. The reporter is broadly expressed in larval stages. The arrow indicates gcy-5::gfp expression (easily visible through the YFP filter used to visualize LSY-2:YFP), whose loss in lsy-2(ot90) animals is completely rescued.
Figure 6che-1 reporter generated by fosmid recombineering.
A. che-1 locus. Complete fosmid coverage of the che-1 locus is shown and the fosmid that was chosen for recombineering is highlighted in red. The pBALU 4 cassette was used to create a C-terminal fusion protein of CHE-1 and mChOpti. B. Embryonic expression. The recombineered fosmid was injected into che-1(ot94) mutant animals. The comma stage embryo displays expression of che-1::mChO in ASEL and ASER (white arrows) and, briefly, in their sister cells as they undergo apoptosis (white arrowheads). C. Larval expression. che-1 expression in maintained in the ASEL/R neurons during larval and adult stages.
Figure 7snb-1 reporter generated by bicistronic fosmid recombineering.
A. snb-1 locus. Complete fosmid coverage of the snb-1 locus is shown and the fosmid that was chosen for recombineering is highlighted in red. The pBALU 10 cassette was used to create a bicistronic locus to express YFP under the control of snb-1 promoter and 3′ UTR while not modifying SNB-1 protein. B. Larval expression. The SL2 engineered bicistronic snb-1 reporter results in yfp expression under the control of snb-1 regulatory elements with the YFP protein being directed to the nucleus of the cells that express snb-1 in the head region of the L2 larval stage. snb-1 expression reported by nuclear YFP can be easily assigned to a broad range of distinct neurons in the head. Anterior is to the top. The white brackets indicate the position of the major head neuropil, the nerve ring. The white arrow indicates an isolated neuronal nucleus in the pharynx, identifiable through its speckled nuclear morphology and expressing YFP.
Figure 8Additional applications of fosmid recombineering.
A. Sequence deletion. λ Red-mediated recombineering can be used to first replace the sequence to be deleted with the FRT-galK-FRT cassette and further Flp-mediated recombination to excise the selectable marker. Note that in this case a 34 bp FRT scar will remain in place of the deleted sequence. B. Sequence replacement. A similar strategy can be used for sequence replacement. The sequence to be added should be included in the recombineering cassette and co-introduced in the fosmid with the FRT-galK-FRT module. As an example we show the replacement of the endogenous 3′ UTR by the generally permissive C. elegans unc-54 3′ UTR. This cassette is provided in pBALU21 and can be used to test whether the expression of a given gene is regulated by sequences in its 3′ UTR. C. Fosmid extension. Recombineering can be used to extend the genomic insert in a fosmid. The pBALU-ext vector is used to amplify the kanamycin (Kan) resistance gene flanked by sequences homologous to the fosmid backbone pCC1FOS and the genomic extension fragment. The genomic fragment is fused by PCR to this cassette generating a Kan cassette flanked by the homology to one end of pCC1FOS and the genomic extension fragment. A single λ Red-mediated recombineering step with subsequent Kan selection accomplishes the extension with Kan gene becoming a permanent part of the fosmid backbone. Note that any of these manipulations can be done in conjunction with additional fluorescent protein or epitope tagging using our double recombineering cassettes with modified FRT sites.